X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (897) 897
Publication (120) 120
Book Chapter (18) 18
Book Review (10) 10
Dissertation (2) 2
Newspaper Article (2) 2
Trade Publication Article (2) 2
Conference Proceeding (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
cd22 (528) 528
humans (498) 498
index medicus (346) 346
animals (321) 321
mice (228) 228
immunology (209) 209
cd22 antigen (184) 184
oncology (164) 164
b-lymphocytes - immunology (154) 154
female (133) 133
hematology (130) 130
biochemistry & molecular biology (123) 123
male (118) 118
lymphocytes b (109) 109
sialic acid binding ig-like lectin 2 (107) 107
rituximab (106) 106
leukemia (102) 102
lectins (99) 99
antibodies, monoclonal - therapeutic use (98) 98
non-hodgkins-lymphoma (95) 95
sialic acid binding ig-like lectin 2 - immunology (94) 94
cancer (92) 92
activation (90) 90
flow cytometry (90) 90
ligands (88) 88
adult (83) 83
hemic and lymphatic diseases (83) 83
lymphocytes (83) 83
receptor (83) 83
cell adhesion molecules (82) 82
monoclonal antibodies (81) 81
b cells (79) 79
humanized anti-cd22 antibody (79) 79
lymphoma (79) 79
monoclonal-antibody (76) 76
article (75) 75
b-lymphocytes - metabolism (74) 74
immunotherapy (73) 73
therapy (73) 73
middle aged (72) 72
signal transduction (69) 69
b-cells (68) 68
molecular sequence data (68) 68
b-cell lymphoma (67) 67
expression (67) 67
antigens (66) 66
epratuzumab (65) 65
antigens, cd - immunology (64) 64
chemotherapy (64) 64
antibodies (63) 63
immune system diseases (62) 62
sialic acid binding ig-like lectin 2 - metabolism (62) 62
research (61) 61
cd22-deficient mice (59) 59
cell line, tumor (59) 59
lymphomas (59) 59
immunoglobulin superfamily (58) 58
antigens, cd - metabolism (57) 57
autoimmunity (56) 56
analysis (55) 55
apoptosis (55) 55
antineoplastic agents - therapeutic use (54) 54
binding (54) 54
negative regulator (54) 54
aged (53) 53
antigens, cd - genetics (53) 53
medicine, research & experimental (53) 53
phosphorylation (52) 52
receptors, antigen, b-cell - metabolism (52) 52
treatment outcome (52) 52
cd19 antigen (51) 51
in-vivo (51) 51
systemic-lupus-erythematosus (50) 50
amino acid sequence (49) 49
chronic lymphocytic-leukemia (49) 49
phase-i (49) 49
t-cells (48) 48
antigen receptor (47) 47
mice, inbred c57bl (47) 47
pharmacology & pharmacy (47) 47
radioimmunotherapy (47) 47
antibodies, monoclonal - immunology (46) 46
antigens, differentiation, b-lymphocyte - immunology (46) 46
antigens, differentiation, b-lymphocyte - metabolism (45) 45
immunotoxin (45) 45
sialic acids (45) 45
b-lymphocytes - drug effects (44) 44
cd19 (43) 43
cell biology (43) 43
cytotoxicity (43) 43
monoclonal antibody (43) 43
proteins (43) 43
signal-transduction (43) 43
cell line (42) 42
antigen (41) 41
care and treatment (41) 41
immunoglobulins (40) 40
myelin-associated glycoprotein (40) 40
rheumatology (40) 40
tumor cells, cultured (39) 39
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


JOURNAL OF IMMUNOLOGY, ISSN 0022-1767, 09/2006, Volume 177, Issue 5, pp. 2994 - 3003
CD22 (Siglec-2) is a key regulator of B cell signaling whose function is modulated by interaction with extracellular glycan ligands mediated through its... 
HUMANIZED ANTI-CD22 ANTIBODY | IMMUNOGLOBULIN SUPERFAMILY | BONE-MARROW | N-GLYCOLYLNEURAMINIC ACID | NON-HODGKINS-LYMPHOMA | PROTEIN CD22 | SIALIC-ACID | MONOCLONAL-ANTIBODY | IMMUNOLOGY | MYELIN-ASSOCIATED GLYCOPROTEIN | MURINE CD22
Journal Article
Cancer Letters, ISSN 0304-3835, 10/2016, Volume 381, Issue 2, pp. 296 - 304
Radioimmunotherapy is considered as treatment option in recurrent and/or refractory B-cell non-Hodgkin lymphoma (B-NHL). To overcome the dose limiting bone... 
Dual-targeting | PEGylation | Lymphoma | CD22 | Diabody | Radioimmunotherapy
Journal Article
British Journal of Haematology, ISSN 0007-1048, 08/2011, Volume 154, Issue 4, pp. 471 - 476
Journal Article
International Journal of Peptide Research and Therapeutics, ISSN 1573-3149, 2019
Journal Article
Chemical Science, ISSN 2041-6520, 2019, Volume 10, Issue 24, pp. 6199 - 6209
The cell membrane contains a highly interactive glycan surface on a scaffold of proteins and lipids. Sialic acids are negatively charged monosaccharides, and... 
CROSS-LINKING | LIGAND | MODEL | EXPRESSION | CHEMISTRY, MULTIDISCIPLINARY | CD22 | PROBES
Journal Article
Chemical science, ISSN 2041-6520, 06/2019, Volume 10, Issue 24, pp. 6199 - 6209
The cell membrane contains a highly interactive glycan surface on a scaffold of proteins and lipids. Sialic acids are negatively charged monosaccharides, and... 
Journal Article
CLINICAL CANCER RESEARCH, ISSN 1078-0432, 09/2019, Volume 25, Issue 17, pp. 5329 - 5341
Purpose: Chimeric antigen receptor T-cell (CART) therapy targeting CD22 induces remission in 70% of patients with relapsed/refractory acute lymphoblastic... 
B-ALL | PROTEIN-KINASE-C | ONCOLOGY | AFFINITY | SENSITIVITY | RECEPTORS | BRYOSTATIN-1 | EXPRESSION | CHILDHOOD | CD22 | TUMOR-ANTIGEN
Journal Article
TRAFFIC, ISSN 1398-9219, 03/2014, Volume 15, Issue 3, pp. 255 - 272
Journal Article
Autoimmunity Reviews, ISSN 1568-9972, 2015, Volume 14, Issue 12, pp. 1079 - 1086
Abstract Epratuzumab is a B-cell-directed non-depleting monoclonal antibody that targets CD22. It is currently being evaluated in two phase 3 clinical trials... 
Allergy and Immunology | Epratuzumab | Biologic therapies | Systemic lupus erythematosus | B cells | CD22 | RHEUMATOID-ARTHRITIS | SIGNAL | MONOCLONAL-ANTIBODY | PERIPHERAL-BLOOD | KAPPA-B | IMMUNOLOGY | TYROSINE-PHOSPHATASE | HUMANIZED ANTI-CD22 ANTIBODY | AUTOIMMUNE-DISEASES | BCR CROSS-TALK | ANTIGEN RECEPTOR | Lupus | Drug therapy | Analysis
Journal Article
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, ISSN 0002-7863, 09/2019, Volume 141, Issue 36, pp. 14032 - 14037
The Siglec family of cell surface receptors have emerged as attractive targets for cell-directed therapies due to their restricted expression on immune cells,... 
DESIGN | EOSINOPHIL | INHIBITORS | LIGAND | IDENTIFICATION | BINDING | CHEMISTRY, MULTIDISCIPLINARY | CD22 | CD33
Journal Article
Traffic, ISSN 1398-9219, 03/2014, Volume 15, Issue 3, pp. 255 - 272
CD22 is a cell surface glycoprotein restricted to normal and malignant B‐cells and is the target of several anti‐CD22 antibody‐based cancer therapies. For... 
Siglec‐2 | DropArray | recycling endosomes | lysosomes | BL‐CAM | B‐cells | CD22 | anti‐CD22 | immunofluorescence | B-cells | Anti-CD22 | BL-CAM | Lysosomes | Siglec-2 | Immunofluorescence | Recycling endosomes | Endocytosis | Microscopy, Fluorescence - methods | Sialic Acid Binding Ig-like Lectin 2 - metabolism | Humans | Cell Line, Tumor | Tissue Array Analysis - methods | B-Lymphocytes - metabolism
Journal Article
Oncotarget, ISSN 1949-2553, 11/2018, Volume 9, Issue 92, pp. 36409 - 36410
Journal Article
Journal Article
CHEMICAL SCIENCE, ISSN 2041-6520, 10/2019, Volume 10, Issue 37, pp. 8600 - 8609
The utilization of immuno-magnetic nanoparticles (MNPs) for the selective capture, enrichment, and separation of specific glycoproteins from complicated... 
B-CELLS | LIGANDS | COVALENT | SELECTIVE ENRICHMENT | FABRICATION | IDENTIFICATION | BINDING | CHEMISTRY, MULTIDISCIPLINARY | MULTIPLEXED IMMUNOASSAY | CD22 | IMMOBILIZATION
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 08/2016, Volume 375, Issue 8, pp. 740 - 753
Journal Article